# An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease

> **NCT01846689** · PHASE3 · UNKNOWN · sponsor: **Targeted Medical Pharma** · enrollment: 30 (estimated)

## Conditions studied

- Anemia of Chronic Disease

## Interventions

- **DRUG:** ESS (medical food/drug)

## Key facts

- **NCT ID:** NCT01846689
- **Lead sponsor:** Targeted Medical Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2013-08
- **Final completion:** 2013-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01846689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01846689, "An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01846689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*